Brian W Dymock Selected Research

Brian W Dymock Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 07/2011
3	Tuberculosis (Tuberculoses) 01/2017 - 01/2016
2	Skin Neoplasms (Skin Cancer) 01/2024 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2018
2	Malaria 08/2016 - 01/2016
2	Lymphoma (Lymphomas) 01/2016 - 07/2011
2	Rheumatoid Arthritis 10/2012 - 03/2012
1	Adenocarcinoma 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Communicable Diseases (Infectious Diseases) 08/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Inflammation (Inflammations) 08/2015
1	Poisoning 06/2014
1	Bone Resorption 10/2012
1	Experimental Arthritis 10/2012
1	Autoimmune Diseases (Autoimmune Disease) 10/2012
1	Arthritis (Polyarthritis) 10/2012
1	Carcinogenesis 04/2012
1	Leukemia 01/2012
1	Multiple Myeloma 01/2012
1	Primary Myelofibrosis (Myelosclerosis) 07/2011

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 12/2017 - 01/2012
4	Tyrosine (L-Tyrosine)FDA Link 10/2012 - 07/2011
3	Janus Kinase 2IBA 03/2012 - 07/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 08/2018
2	A131 compoundIBA 01/2019 - 08/2018
2	EnzymesIBA 01/2018 - 04/2013
2	GYY 4137IBA 01/2017 - 01/2017
2	Proteasome InhibitorsIBA 01/2017 - 01/2017
2	Chloroquine (Aralen)FDA LinkGeneric 08/2016 - 01/2016
2	15- (2- (pyrrolidin- 1- yl)ethoxy)- 7,12,25- trioxa- 19,21,24- triazatetracyclo(18.3.1.1(2,5).1(14,18))hexacosa- 1(24),2,4,9,14(26),15,17,20,22- nonaeneIBA 10/2012 - 03/2012
1	Calcineurin InhibitorsIBA 01/2024
1	ProdrugsIBA 01/2019
1	SaltsIBA 01/2019
1	Drug CombinationsIBA 01/2018
1	Vorinostat FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	LigandsIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017
1	LipidsIBA 12/2017
1	DipeptidesIBA 01/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Boronic AcidsIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	Protons (Proton)IBA 01/2017
1	SodiumIBA 01/2017
1	compound 17IBA 01/2017
1	AnionsIBA 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Simvastatin (Zocor)FDA LinkGeneric 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 09/2016
1	artemisinin (artemisinine)IBA 08/2016
1	Leucine (L-Leucine)FDA Link 01/2016
1	AntioxidantsIBA 01/2016
1	tazemetostatIBA 01/2016
1	Caspase 7IBA 08/2015
1	ParaquatIBA 06/2014
1	Janus KinasesIBA 04/2013
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 04/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2012
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 01/2012
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 07/2011
1	Histone Deacetylase InhibitorsIBA 07/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2011

Therapy/Procedure

13	Therapeutics 01/2024 - 07/2011
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2016